Evidence map›Paper›PMID 38495526›Full record

ReviewEClinicalMedicine2024

Population-level interventions for the primary prevention of dementia: a complex evidence review.

Sebastian Walsh, Lindsay Wallace, Isla Kuhn, Oliver Mytton, Louise Lafortune, Wendy Wills, Naaheed Mukadam, Carol Brayne

Abstract readReview
In one paragraph

Review in EClinicalMedicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Involving Societal Stakeholders in Dementia Risk Reduction: An Explorative Study.Health expectations : an international journal of public participation in health care and health policy · 2026
    Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Estimating the impact of risk factor reduction on dementia prevalence in New Zealand.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  14. Observational
  15. Article
  16. Article
  17. Article
  18. Article
  19. Thinking outside the brain: Gut microbiome influence on innate immunity within neurodegenerative disease.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2024
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Sebastian WalshCambridge Public Health, University of Cambridge, Cambridge CB2 0SR, UK.
Lindsay WallaceCambridge Public Health, University of Cambridge, Cambridge CB2 0SR, UK.
Isla KuhnUniversity of Cambridge Medical School Library, School of Clinical Medicine, Cambridge CB2 0SP, UK.
Oliver MyttonGreat Ormond Street Institute of Child Health, University College London, London WC1N 1EH, UK.
Louise LafortuneCambridge Public Health, University of Cambridge, Cambridge CB2 0SR, UK.
Wendy WillsCentre for Research in Public Health and Community Care, University of Hertfordshire, Hatfield AL10 9AB, UK.
Naaheed MukadamDivision of Psychiatry, University College London, London W1T 7BN, UK.
Carol BrayneCambridge Public Health, University of Cambridge, Cambridge CB2 0SR, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dementia risk reduction is a global public health priority. Existing primary prevention approaches have favored individual-level interventions, with a research and policy gap for population-level interventions. We conducted a complex, multi-stage, evidence review to identify empirical evidence on population-level interventions for each of the modifiable risk factors identified by the Lancet Commission on dementia (2020). Through a comprehensive series of targeted searches, we identified 4604 articles, of which 135 met our inclusion criteria. We synthesized evidence from multiple sources, including existing non-communicable disease prevention frameworks, and graded the consistency and comprehensiveness of evidence. We derived a population-level intervention framework for dementia risk reduction, containing 26 high- and moderate-confidence policy recommendations, supported by relevant information on effect sizes, sources of evidence, contextual information, and implementation guidance. This review provides policymakers with the evidence they need, in a useable format, to address this critical public health policy gap. Funding: SW is funded by a National Institute for Health and Care Research (NIHR) Doctoral Fellowship. WW and LF are part funded by the NIHR Applied Research Collaboration East of England. The views expressed are those of the authors and not necessarily those of the NIHR or the Department of Health and Social Care.

Identifiers

PMID38495526
PMCPMC10940136

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.